In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...

Chronic myelomonocytic leukemia rarely occurs in young people and is typically diagnosed in individuals older than age 60 years, with a median age at diagnosis of 70 to 75 years. In general ...

Leukemia can refer to all cancers affecting the white blood cells. How the cancer spreads can depend on the type of leukemia and how aggressive it is. Leukemia is a cancer of the blood cells ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

F.L.L. is supported by the Leukemia and Lymphoma Society as a Clinical Scholar, and the NCI (R01CA244328, P30-CA076292). S.S. is supported by Stanford Clinical and Translational Science KL2 Career ...

Medicare plans include benefits that can help with leukemia treatment costs. Out-of-pocket expenses may apply, and additional support may be available. Medicare covers many of the costs of care ...

Leukemia is a blood or bone marrow cancer that produces blood cells. Leukemia occurs due to a problem with blood cell production. It usually affects the leukocytes or white blood cells. Leukemia ...

Dr. Porter is the Jodi Fisher-Horowitz Professor of Leukemia Care Excellence in the Perelman School of Medicine at the University of Pennsylvania and Abramson Cancer Center, as well as the ...